In vivo inhibition of angiogenesis by a soluble form of melanotransferrin

Carcinogenesis

Volumn 28, Issue 2, 2007, Pages 280-288

  Michaud Levesque, Jonathan ^a   Demeule, Michel ^a   Béliveau, Richard ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; MELANOMA ANTIGEN; MELANOTRANSFERRIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CELL CULTURE; CONTINUOUS INFUSION; CONTROLLED STUDY; CULTURE MEDIUM; DRUG BLOOD LEVEL; DRUG MECHANISM; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MAXIMUM PLASMA CONCENTRATION; MELANOMA CELL; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; UMBILICAL CORD BLOOD;

ANGIOGENESIS INHIBITORS; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 2; HUMANS; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PLASMIN; RECOMBINANT PROTEINS; SOLUBILITY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33847251150     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl123     Document Type: Article

References (33)

1. Brown,J.P., HewickR.M., Hellstrom,I., Hellstrom,K.E., Doolittle,R.F. and Dreyer,W.J. (1982) Human melanoma-associated antigen p97 is structurally and functionally related to transferrin. Nature, 296, 171-173.
2. Brown,J.P., Woodbury,R.G., Hart C.E., Hellstrom,I. and Hellstrom,K.E. (1981) Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues. Proc. Natl Acad. Sci. USA, 78, 539-543.
3. Food,M.R., Rothenberger,S., Gabathuler,R., Haidl,I.D., Reid,G. and Jefferies,W.A. (1994) Transport and expression in human melanomas of a transferrin-like glycosylphosphatidylinositol-anchored protein. J. Biol. Chem., 269, 3034-3040.
4. Sekyere,E.O., Dunn,L.L. and Richardson,D.R. (2005) Examination of the distribution of the transferrin homologue, melanotransferrin (tumour antigen p97), in mouse and human. Biochim Biophys. Acta, 1722, 131-142.
5. Food,M.R., Sekyere,E.O. and Richardson,D.R. (2002) The soluble form of the membrane-bound transferrin homologue, melanotransferrin, inefficiently donates iron to cells via nonspecific internalization and degradation of the protein. Eur. J. Biochem, 269, 4435-4445.
6. Sekyere,E. and Richardson,D.R. (2000) The membrane-bound transferrin homologue melanotransferrin: Roles other than iron transport? FEBS. Lett, 483, 11-16.
7. Sekyere,E.O., Dunn,L.L., Suryo Rahmanto,Y. and Richardson,D.R. (2005) Role of melanotransferrin in iron metabolism: Studies using targeted gene disruption in vivo. Blood, 107, 2599-2601.
8. Demeule,M., Bertrand,Y., Michaud-Levesque,J., Jodoin,J., Rolland,Y., Gabathuler,R. and Beliveau,R. (2003) Regulation of plasminogen activation: A role for melanotransferrin (p97) in cell migration. Blood, 102, 1723-1731.
9. Michaud-Levesque,J., Demeule,M. and Beliveau,R. (2005) Stimulation of cell surface plasminogen activation by membrane-bound melanotransferrin: a key phenomenon for cell invasion. Exp. Cell Res., 308, 479-490.
10. Carmeliet,P. (2005) Angiogenesis in life, disease and medicine. Nature, 438, 932-936.
11. Papetti,M. and Herman,I.M. (2002) Mechanisms of normal and tumor-derived angiogenesis. Am. J. Physiol. Cell Physiol., 282, C947-C970.
12. Michaud-Levesque,J., Rolland,Y., Demeule,M., Bertrand,Y. and Beliveau,R. (2005) Inhibition of endothelial cell movement and tubulogenesis by human recombinant soluble melanotransferrin: Involvement of the u-PAR/ LRP plasminolytic system. Biochim. Biophys. Acta, 1743, 243-253.
13. Passaniti,A., Taylor,R.M., Pili,R., Guo,Y., Long,P.V., Haney,J.A., Pauly,R.R., Grant,D.S. and Martin,G.R. (1992) A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest, 67, 519-528.
14. McMahon,G.A., Petitclerc,E., Stefansson,S., Smith,E., Wong,M.K., Westrick,R.J., Ginsburg,D., Brooks,P.C. and Lawrence,D.A. (2001) Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J. Biol. Chem., 276, 33964-33968.
15. Min,J.K., Han,K.Y., Kim,E.C., Kim,Y.M., Lee,S.W., Kim,O.H., Kim,K.W., Gho,Y.S. and Kwon,Y.G. (2004) Capsaicin inhibits in vitro and in vivo angiogenesis. Cancer Res., 64, 644-651.
16. Miles,L.A., Dahlberg,C.M., Plescia,J., Felez,J., Kato,K. and Plow,E.F. (1991) Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. Biochemistry, 30, 1682-1691.
17. Plow,E.F., Herren,T., Redlitz,A., Miles,L.A. and Hoover-Plow,J.L. (1995) The cell biology of the plasminogen system. FASEB J., 9, 939-945.
18. Reijerkerk,A., Voest,E.E. and Gebbink,M.F. (2000) No grip, no growth: the conceptual basis of excessive proteolysis in the treatment of cancer. Eur. J. Cancer, 36, 1695-1705.
19. Sala,R., Jefferies,W.A., Walker,B. et al. (2002) The human melanoma associated protein melanotransferrin promotes endothelial cell migration and angiogenesis in vivo. Eur. J. Cell Biol., 81, 599-607.
20. Lazar-Molnar,E., Hegyesi,H., Toth,S. and Falus,A. (2000) Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine, 12, 547-554.
21. Cavallaro,U., Tenan,M., Castelli,V., Perilli,A., Maggiano,N., Van Meir,E.G., Montesano,R., Soria,M.R. and Pepper,M.S. (2001) Response of bovine endothelial cells to FGF-2 and VEGF is dependent on their site of origin: Relevance to the regulation of angiogenesis. J. Cell. Biochem., 82, 619-633.
22. Rakic,J.M., Maillard,C., Jost,M., Bajou,K., Masson,V., Devy,L., Lambert,V., Foidart,J.M. and Noel,A. (2003) Role of plasminogen activator-plasmin system in tumor angiogenesis. Cell. Mol. Life Sci., 60, 463-473.
23. Gowardhan,B., West,A.F., Robson,C.N. and Leung,H.Y. (2004) Adenovirus-mediated expression of a soluble fibroblast growth factor receptor inhibits in vitro growth of prostate DU145 cells. Prostate, 61, 50-59.
24. Luo,W., Liu,A., Chen,Y. et al. (2004) Inhibition of accelerated graft arteriosclerosis by gene transfer of soluble fibroblast growth factor receptor-1 in rat aortic transplants. Arterioscler. Thromb. Vasc. Biol., 24, 1081-1086.
25. Borkham-Kamphorst,E., Stoll,D., Gressner,A.M. and Weiskirchen,R. (2004) Inhibitory effect of soluble PDGF-beta receptor in culture-activated hepatic stellate cells. Biochem. Biophys. Res. Commun., 317, 451-462.
26. Kou,B., Li,Y., Zhang,L., Zhu,G., Wang,X., Li,Y., Xia,J. and Shi,Y. (2004) In vivo inhibition of tumor angiogenesis by a soluble VEGFR-2 fragment. Exp. Mol. Pathol.,76, 129-137.
27. Jo,M., Thomas,K.S., Wu,L. and Gonias,S.L. (2003) Soluble urokinase-type plasminogen activator receptor inhibits cancer cell growth and invasion by direct urokinase-independent effects on cell signaling. J. Biol. Chem., 278, 46692-46698.
28. Arao,T., Yanagihara,K., Takigahira,M., Takeda,M., Koizumi,F., Shiratori,Y. and Nishio,K. (2005) ZD6474 inhibits tumor growth and intraperitoneal dissemination in a highly metastatic orthotopic gastric cancer model. Int J Cancer., 118, 483-489.
29. Ferguson,D., Rodriguez,L.E., Palma,J.P. et al. (2005) Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft models. Clin. Cancer Res., 11, 3045-3054.
30. Drixler,T.A., Borel Rinkes,I.H., Ritchie,E.D., van Vroonhoven,T.J., Gebbink,M.F. and Voest,E.E. (2000) Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy. Cancer Res., 60, 1761-1765.
31. Kim,D.K., Seo,M.Y., Lim,S.W., Kim,S., Kim,J.W., Carroll,B.J., Kwon,D.Y., Kwon,T. and Kang,S.S. (2001) Serum melanotransferrin, p97 as a biochemical marker of Alzheimer's disease. Neuropsychopharmacology, 25, 84-90.
32. Kennard,M.L., Feldman,H., Yamada,T. and Jefferies,W.A. (1996) Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease. Nat. Med., 2, 1230-1235.
33. Ujiie,M., Dickstein,D.L. and Jefferies,W.A. (2002) p97 as a biomarker for Alzheimer disease. Front Biosci., 7, e42-e47.